Tag Archive for: Acquisition

Canadian Fusion Therapeutics Inc is utilising the advantages of alpha medical isotopes to develop targeted alpha therapies. The company uses targeting molecules, such as antibodies, armed with potent alpha emitting isotopes to precisely and effectively induce cancer cell death by induction of DNA double strand breaks. © Fusion Therapeutics Inc
acquisition

AstraZeneca to take over Fusion Therapeutics Inc

British pharma giant AstraZeneca has announced to acquire radio-conjugate specialist Fusion Therapeutics Inc for US$2bn upfront.

Read more
AstraZeneca Cambridge headquarters © wikipedia.org/D_Wells
acquisition

AstraZeneca to acquire Amolyt Pharma for up to US$1.05bn

French endocrine diseases specialist Amolyt Pharma SA has entered into a take-over agreement by AstraZeneca.

Read more
© Ralphs_Fotos/pixabay.com
M&A

VectivBio taken over in $1bn acquisition

GI specialist Ironwood Pharmaceuticals Inc. has announced to acquire Swiss VectivBio Holding AG for $17 per share in an all-cash transaction.

Read more
© mirerek8 / Pixabay
Acquisition

VectivBio expands rare disease pipeline

Swiss rare disease specialist VectivBio Holding AG is taking over US biotech Comet Therapeutics Inc. for an undisclosed amount. Comet focusses on treatments for metabolic diseases.

Read more